Jonathan Peacock elected Chairman of the Board of Directors of Avantor
Peacock also serves as a Director and Chair of the Audit and Finance Committee of UCB SA, a biopharmaceutical company focusing on neurology and immunology
Peacock also serves as a Director and Chair of the Audit and Finance Committee of UCB SA, a biopharmaceutical company focusing on neurology and immunology
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
The study, presented at the European Stroke Organisation Conference (ESOC 2022) pinpointed specific groups of bacteria associated with poorer neurological recovery from ischaemic stroke both in the acute phase (24 hours) and after three months
This RT-PCR diagnostic kit helps in diagnosis of AS by detecting HLAB27 gene
The planned Phase 1 study is a double-blind, randomized, placebo-controlled dose-escalation study in healthy adult subjects and AD patients
It affects up to 10 per cent of women of reproductive age around the world
Revenue from operations up 15% to Rs. 758 crore in fourth quarter
This is the first major brand refresh of CanSinoBIO since its inception in 2009
It supports advanced research and helps scientists accelerate potential cures, drug discoveries and diagnostics research
These distinct gut microbial signatures can be used to predict the risk of developing long Covid and diagnose long Covid in patients with persistent symptoms after the acute infection
Subscribe To Our Newsletter & Stay Updated